The Age of Phage - Pharmaceutical Business Review

More White Papers

Published 08 July 2011 | By Phage Consultants

A new surge of interest in bacteriophages has led to revived investment in this niche research area despite a history of failed commercialisation. But how can today's techniques overcome yesterday's mistakes?

As a registered user of PBR you can skip the majority of this form. Registration is FREE so register now or log in if you're already a member.

Fill In Details

Title* First Name* Last Name* Email* Confirm Email* Telephone* Reason for Download*

Job Title* Job Function* If other job function please specify Company* Country* Company Activity If other company activity please specify

Help us to better improve our communications by entering all or some of the additional fields below, then click 'Download White Paper' to be taken to the next page.

AddressLine1 AddressLine2 City County/State Zip

Fax Company Turnover Number of Employees Role In Purchasing

Complete a quick security check and confirm terms and conditions

This step helps prevent unfair use of automated programs.

Type both words separated by a space below*

I have read and accept the terms and conditions and privacy policy.

We'd like to keep you informed about relevant promotions, products and services, or if you would prefer not to receive these, uncheck this box.

If you would prefer not to hear from carefully selected third party companies uncheck this box

By clicking the 'download white paper' button you agree to pass your details as shown to the white paper advertiser. The enquirer also permits the advertiser to follow up the enquiry by phone or email. PBR is in no way responsible for further communication between parties.
Fields marked * are compulsory

Related Intelligence and Suppliers

White Papers

The Age of Phage Phage Consultants White Papers

Contamination Concerns Phage Consultants White Papers

Contamination Problems? We Solve Them Phage Consultants White Papers

Latest Products

Phage Production We offer phage production and purification. What distinguish us from other CMOs is our extensive knowledge about requirements of phages to grow to high titres, and the guarantee, that the phage you would like us to produce, will be the same we deliver to you. We know how to avoid phage cross-contamination, and we know how to obtain the highest amount of bacteriophages in single fermentation. Just imagine, how optimization of effectivity of phage production by just 1 order of magnitude influences the cost of production and purification. Products

Production & Manufacturing Fine & Speciality Chemicals Manufacturing Process & Production OTC
Drug Research Drug Delivery Drug Discovery & Development
Contract Research & Services Clinical Trials Contract Research Contract Services
Automation IT & Software Laboratory Instrumentation
Inward Investment Packaging Regulatory Affairs

# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z